Member Spotlight: @AnishJayJain
An aspiring academic surgical oncologist, Dr. Jain is advancing research in complex gastrointestinal cancers while supporting the next generation of surgeons through education & mentorship.
@rajarnarayan@ChataniMD@StanfordSurgery@maryhawn
Grateful to be a part of this phenomenal opportunity from @SocSurgOnc! Can’t wait to see everyone in Phoenix and looking forward to an awesome year with my mentorship program colleagues 🙏🏻💯 #SSO2026
Thanks for the shoutout @SSATNews. I have grown so much and established many professional relationships through the Resident and Fellow Education Committee. Highly recommend getting involved!
Whether or not you seek a career in clinical trials, understanding the where/how of trial development and, at a minimum, developing an appreciation for its difficulty, is a prerequisite for a career in medicine. So grateful to @MichaelDAngeli2 and @SyedAAhmad5 for making time.
“Climbing The Ladder of Academic Surgery” with @JeffreyFarma. A must-listen for all senior trainees and junior faculty.
Grateful to @SSATNews for the opportunity to share my conversation with a remarkable surgeon in possssion of seemingly unlimited bandwidth.
Mentor of the month:
Get to know Dr. Jeffrey M. Farma, Chair and Professor of Surgery at Fox Chase Cancer Center. Discover his insights and mentorship journey in this exclusive interview.
Read more: https://t.co/Zs2mFRpxIH
Praveen Chatani, MD, a Complex General Surgical Oncology Fellow, presented research at the @SocSurgOnc 2025 Annual Meeting challenging the current standard of care for staging colon cancer, which calls for removal and examination of 12 lymph nodes: https://t.co/5ccP5byqWd
Results from a study presented by Fox Chase's Hannah Buettner, MD, at the @SocSurgOnc 2025 Annual Meeting suggest that chemotherapy followed by local excision is a promising treatment option for patients with node-negative low rectal cancer: https://t.co/rnn4SnBk8c
Great turnout of #NCISurgOncAlumni at #SSO2025. Celebrated our legacy of translational immunotherapy, Steve Rosenberg and the early pioneers that came thru the surgery branch, (re)connected with alumni/trainees, and laid plans for the future. @sitcancer@SocSurgOnc
Honored to have the privilege of the podium and fortunate to benefit from @AMVillanoMD’s mentorship daily. A massive team effort by my colleagues at @FoxChaseSurgOnc and overall well received on the #SSO2025 stage.
All-star 1st year FCCC fellow @ChataniMD discussing why we should consider moving the goalpost up a bit for lymph node targets in colon cancer! Proud of all his work on an important topic with measurable benefits! 💯🔥@FoxChaseSurgOnc#SSO2025
Lights💡Camera 🎥 Action 🎬! Up close and personal with the one and only @JeffreyFarma of @FoxChaseCancer for an episode of the @SSATNews Mentor of the Month series. “Climbing the Academic Ladder” coming soon to a screen near you 👀.
A true team effort! Fortunate to have great stats support and mentorship @FoxChaseSurgOnc (@AMVillanoMD). Thank you to @PhilAcadSurgery for the opportunity to present and for highlighting our work. Catch us @SocSurgOnc on 3/27 in the 1:50pm colorectal session (Rm 122-123)!
Proud of @FoxChaseCancer first year fellow @ChataniMD taking home 1st prize in the @PhilAcadSurgery research comp! Tremendous amount of thought and work, well deserved! 🔥💯 Will certainly generate needed conversations re: node targets & proper staging at @SocSurgOnc in March
Huge thank you to @PhilAcadSurgery for the opportunity to present our study which defines a new target lymphadenectomy in oncologic colectomies. Absolute masterclass by @FoxChaseCancer statistician Jordan Fredette, guided by @AMVillanoMD. Excited to share this work @SocSurgOnc!
@TheChiefNerd The FDA literally just approved an anti-amyloid monoclonal antibody treatment that showed clinical efficacy in phase 3 trials. This week. It represents THE most significant breakthrough in Alzheimer’s treatment of the century.
@VPrasadMDMPH As a fellow at the NIH, did you not rely on this funding to present your research at conferences and further your own education/career? Would you have the platform you have today had it not been for the opportunities created by this funding?